- Home
- INM vs PD Comparison
INM vs PD Comparison
Compare INM & PD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- INM
- PD
- Stock Information
- Founded
- INM 1981
- PD 2009
- Country
- INM Canada
- PD United States
- Employees
- INM N/A
- PD N/A
- Industry
- INM Biotechnology: Pharmaceutical Preparations
- PD Computer Software: Prepackaged Software
- Sector
- INM Health Care
- PD Technology
- Exchange
- INM Nasdaq
- PD Nasdaq
- Market Cap
- INM 5.0M
- PD 1.5B
- IPO Year
- INM N/A
- PD 2019
- Fundamental
- Price
- INM $2.04
- PD $16.21
- Analyst Decision
- INM
- PD Hold
- Analyst Count
- INM 0
- PD 9
- Target Price
- INM N/A
- PD $18.33
- AVG Volume (30 Days)
- INM 116.2K
- PD 2.0M
- Earning Date
- INM 11-13-2025
- PD 11-25-2025
- Dividend Yield
- INM N/A
- PD N/A
- EPS Growth
- INM N/A
- PD N/A
- EPS
- INM N/A
- PD N/A
- Revenue
- INM $4,942,633.00
- PD $483,608,000.00
- Revenue This Year
- INM N/A
- PD $9.16
- Revenue Next Year
- INM N/A
- PD $6.79
- P/E Ratio
- INM N/A
- PD N/A
- Revenue Growth
- INM 7.50
- PD 8.20
- 52 Week Low
- INM $1.72
- PD $13.70
- 52 Week High
- INM $8.27
- PD $21.98
- Technical
- Relative Strength Index (RSI)
- INM 42.37
- PD 54.03
- Support Level
- INM $2.04
- PD $15.50
- Resistance Level
- INM $2.26
- PD $16.23
- Average True Range (ATR)
- INM 0.14
- PD 0.45
- MACD
- INM -0.01
- PD 0.03
- Stochastic Oscillator
- INM 10.44
- PD 62.98
About INM InMed Pharmaceuticals Inc.
InMed Pharmaceuticals Inc is a Canada based clinical-stage biopharmaceutical company. The Company's operations consist of two operating and reportable segments, the InMed Pharma segment and the BayMedica Commercial segment. The InMed Pharma segment is largely organized around the research and development of small molecule pharmaceuticals drug candidates and the BayMedica Commercial segment is largely organized around manufacturing technologies to produce and commercialize bulk rare cannabinoids for sale as ingredients in the health and wellness industry. Its product portfolio includes INM-755, which is used for the treatment of epidermolysis bullosa; INM-088 for the treatment of glaucoma; INM-901 for Alzheimer's disease.
About PD PagerDuty Inc.
PagerDuty Inc is a digital operations management platform that manages urgent and mission-critical work for a modern, digital business. Its PagerDuty Operations Cloud combines artificial intelligence (AI) operations (AIOps), automation, customer service operations, and incident management with a generative AI assistant to create a flexible, resilient, and scalable platform to protect revenue and improve customer experience, improve operational efficiency, and mitigate the risk of operational failures. The company generates revenue predominantly from cloud-hosted software subscription fees and term-license software subscription fees. Geographically, the firm derives a majority of its revenue from the United States and the rest from International markets.